🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

14+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 14 of 14 recruiting trials for “well-differentiated-liposarcoma”

Phase 1, PHASE2RecruitingNCT06498648 ↗

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

👨‍⚕️ Elise F Nassif, University of Texas MD Anderson Cancer Center LAO📍 1 site📅 Started Mar 2026View details ↗
NARecruitingNCT07068542 ↗

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

👨‍⚕️ Minghua Ge, Zhejiang Provincial People's Hospital📍 1 site📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT06860971 ↗

A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 35 sites📅 Started Apr 2025View details ↗
Phase 3RecruitingNCT06422806 ↗

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

👨‍⚕️ Seth M Pollack, ECOG-ACRIN Cancer Research Group📍 247 sites📅 Started Sep 2024View details ↗
RecruitingNCT07377747 ↗

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

👨‍⚕️ Angela Hong, Chris O'Brien Lifehouse📍 9 sites📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06440850 ↗

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation

👨‍⚕️ Sasan Fazeli, City of Hope Medical Center📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06389799 ↗

A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)

🏥 Lund University Hospital📍 4 sites📅 Started Jun 2024View details ↗
Phase 1RecruitingNCT05711615 ↗

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

👨‍⚕️ Candace L Haddox, Dana-Farber - Harvard Cancer Center LAO📍 16 sites📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT06359847 ↗

Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer

👨‍⚕️ Yansong Lin, Ph D, Peking Union Medical College Hospital📍 1 site📅 Started Nov 2023View details ↗
RecruitingNCT05994365 ↗

Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 3 sites📅 Started Aug 2023View details ↗
Phase 1RecruitingNCT05607095 ↗

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

👨‍⚕️ Alexander Shoushtari, MD, Memorial Sloan Kettering Cancer Center📍 2 sites📅 Started Nov 2022View details ↗
RecruitingNCT06436846 ↗

Genomic Risk in Retroperitoneal Sarcoma

🏥 Fox Chase Cancer Center📍 1 site📅 Started Mar 2022View details ↗
Phase 1, PHASE2RecruitingNCT04785196 ↗

APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

👨‍⚕️ Ye Guo, MD, PhD, Shanghai East Hospital📍 3 sites📅 Started May 2021View details ↗
RecruitingNCT04699292 ↗

International Prospective Registry on Local Treatment Approaches in MLS

👨‍⚕️ Rick Haas, MD/PhD, The Netherlands Cancer Institute📍 1 site📅 Started Jan 2021View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →